This fall, members of the cancer research community will gather for the inaugural Mark Ernsting Drug Discovery Memorial Lecture. The Lecture is named in honour of Dr. Mark Ernsting, who was a Senior Biomedical Engineer in the Drug Discovery Program at OICR. Dr. Ernsting passed away in December 2015. He was a brilliant and passionate scientist and a great colleague and friend. Dr. Ernsting endeavoured to improve the lives of cancer patients by developing nanomedicines designed to deliver more effective drugs that minimize toxicity.
Date: September 22, 2016
Time: 3-5 p.m.
Location: The Great Hall, Hart House, University of Toronto
Keynote speaker: Dr. Stuart Schreiber, Broad Institute of Harvard and MIT